|
|
|
|
| With a third wave of biologics patents expiring, the race is on to seize the booming opportunities in the fast-evolving biosimilars field. What’s driving the patent scramble? What hurdles in manufacturing, regulation, and market access must be cleared for biosimilars to thrive? And how are global industry leaders carving out strategies to dominate the market? Don’t miss Bioprocess Online Live happening February 4th. Registration is completely free, thanks to the support of Cytiva. |
|
|
DECEMBER'S BEST FEATURED EDITORIAL |
|
|
Research Explores Alternative To EU-Banned Triton X-100 | By Onur Arslan, Robert Weik, and Philipp Mundsperger, Polymun Scientific; Sam Pallerla, Daniel Craig, Ryan Swoyer, and Tracy Blumen, IAVI | One of the best-known viral inactivation agents is now banned in the EU. A group of scientists explored Virodex TXR-1 as a suitable alternative. Here's what they found. |
|
|
Cell Culture Trends To Watch In 2025 | A conversation with Benjamin Bayer, Francisco Conesa Buendía, and Susan Sharfstein | Three upstream processing experts weigh in on advancements from the past year and what they're looking forward to in the year ahead. |
|
|
|
DECEMBER'S BEST INDUSTRY INSIGHTS |
|
|
Addressing Large Molecule Purification Challenges | By Bio-Rad Laboratories, Inc. | Delve into innovative strategies to surmount purification challenges, including design of experiments (DOE) methodologies and insightful case studies centered around plasma protein and virus purification. |
|
|
Best Practices In Fermentation Bioprocess Development | By Culture Biosciences | Stefan De Kok, Director of Fermentation at Zymergen, shared his work in biomanufacturing R&D, as well as the DARPA project he worked on and the importance of fermentation expertise in biomanufacturing. |
|
|
|
DECEMBER'S BEST SOLUTIONS |
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|